| | (i) Since December 31, 2004, no event, change, effect, development or occurrence shall have occurred that, individually or in the aggregate, when taken with all other events, changes, effects, developments and occurrences (A) is, or would reasonably be expected to be, material and adverse to the assets and liabilities (taken together), financial condition or business of the Company and its subsidiaries (taken as a whole), (B) would reasonably be expected to materially and adversely affect the ability of the Company to consummate the Acquisition or would prevent the Company from performing or materially delay the ability of the Company to perform, its obligations under the Merger Agreement or (C) is or would reasonably be expected to materially and adversely affect the rights and remedies of the Administrative Agent or the Lenders under the applicable loan documentation (collectively, a “Material Adverse Effect”); provided, that no change or effect resulting from any of the following shall be deemed, either alone or in combination, to constitute a Material Adverse Effect: (a) a prospective change arising out of any legislation, proposal or enactment by any Governmental Entity (as defined in the Merger Agreement) that is proposed, adopted or enacted after the date of the Merger Agreement; (b) changes in the general conditions of the economy, financial markets, currency markets or commodity markets, whether foreign, domestic or global (including trade embargoes and changes in interest rates), in each case that does not have a disproportionate effect on the Company and its subsidiaries (taken as a whole) (c) acts of war, terrorism, sabotage or civil strife; (d), announcement of the execution and delivery of the Merger Agreement or of the transactions contemplated thereby (e) conditions affecting the industry of the Company and its subsidiaries generally that do not have a disproportionate effect on the Company and its subsidiaries (taken as a whole); (f) the taking of any action expressly required by the Merger Agreement or acts or omissions of the Company taken with the prior written consent of Borrower; and (g) the actions taken by the Company and listed on Section 1.01 of the Company Disclosure Schedule (as defined in the Merger Agreement); provided, further, that in no event shall a change in the trading prices of the Company’s Class A Common Stock, by itself, be considered a Material Adverse Effect. |
| | (ii) Since May 10, 2005, no new or additional information shall have been received or discovered by the Joint Lead Arrangers, regarding the Borrower, the Company and their respective subsidiaries or the Transaction that is inconsistent in a material and adverse manner with the written information received prior thereto (the “Pre-Commitment Information”). |